Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference
TORONTO, June 16, 2022 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that its CEO and Chairman, Arun Menawat, will participate in a virtual panel discussion on Focused Ultrasound hosted by Joshua Jennings, M.D., Managing Director, Health Care – Medical Supplies & Devices, at Cowen’s 7th Annual FutureHealth Conference on Thursday, June 23, 2022 at 9:55 a.m. Eastern Time.